JPRN-jRCT2080221819未知3 期
A short-term administration study of aripiprazole in children and adolescents (age: 6 to 17 years) with autistic disorder
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •1)- The patient meets current DSM-IV-TR diagnostic criteria for Autistic Disorder (defined in DSM-IV-TR) and also demonstrates behaviors such as tantrums, aggression, self-injurious behavior, or a combination of these problems.
- •2) Inpatient or outpatient status
排除标准
- •1) The patient is currently diagnosed with another disorder on the autism spectrum in DSM-IV-TR, including Asperger's, Rett's Disorder, PDD-NOS, Childhood Disintegrative Disorder, or Fragile-X Syndrome.
- •2) Patients who fall under a contraindication listed in the ABILIFY package insert
研究者
相似试验
未知
3 期
ong-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients with Major Depressive DisorderMajor Depressive DisorderJPRN-jRCT2080220699Otsuka Pharmaceutical Co., Ltd.100
未知
3 期
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderAutistic Disorder, Children and AdolescentsJPRN-jRCT2080221820Otsuka Pharmaceutical Co., Ltd.
已完成
不适用
Observational study of the effect of aripiprazole on waking difficultyPatient being treated for depression with difficulty waking up for which aripiprazole was prescribedJPRN-UMIN000048309Kurume University School of Medicine12
已完成
4 期
Aripiprazole effect in the treatment of residual symptoms in patients with schizophreniaIRCT2017013032236N3Vice chancellor for research, Mazandaran University of Medical Sciences50
未知
4 期
Post Marketing Clinical Study of Aripiprazole in Patients with Schizophrenia - Effects on Glucose MetabolismSchizophreniaJPRN-jRCT1080220320Otsuka Pharmaceutical Co., Ltd.